← 產業報告目錄

Healthcare Dispensing Systems Market by Type (Automatic, Manual, Dispensing Component, Control System), Material (Reagent, Antibody, Powder), Application (Drug Delivery, Microfluidics), End User (Hospital, Pharmacy) & Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-07-18頁數 406報告編號 HIT9439

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The healthcare dispensing systems market is projected to reach USD 6.27 billion by 2030 from USD 4.61 billion in 2025, at a CAGR of 6.3% during the forecast period. The growing demand for precision, automation, and efficiency in life sciences and clinical applications drives pharmaceutical and biotechnology companies to shift toward high-throughput screening and personalized medicine. As a result, there is a rising need for accurate and contamination-free liquid handling systems. Concerns about advanced dispensing systems, high costs, and integration issues with other laboratory systems can hinder the growth of the healthcare dispensing systems market to some extent over the forecast period. “Diagnostic & Point-of-care testing management is the fastest growing application segment in the healthcare dispensing systems market during the forecast period.” By application, the healthcare dispensing systems market is segmented into pharmaceutical & biotechnology, diagnostic & point-of-care testing management, medical device manufacturing, pharmacy management, and other applications. Among these, the diagnostic & point-of-care testing management is the fastest-growing segment, driven by the increasing demand for rapid, decentralized testing and the global focus on early disease detection. This segment covers applications such as lateral flow assays (LFAs), PCR and NAAT tests, ELISA, microarrays, and microfluidic devices, each requiring accurate and repeatable dispensing of reagents and samples. Growth is fueled by the expansion of molecular diagnostics, rising infectious disease surveillance, and the growing availability of compact, high-throughput testing platforms. The need for precision, speed, and automation in producing consistent diagnostic results has led to the widespread adoption of automated dispensing systems that reduce variability, ensure traceability, and support large-scale manufacturing of test kits. “Liquids are the fastest growing segment in the healthcare dispensing systems market, by dispensing material, during the forecast period.” By dispensing material, the healthcare dispensing systems market is segmented into liquids; powders, granules, lyophilized materials; and other dispensing materials. Among these, the liquid segment is projected to grow at the fastest rate during the forecast period due to its critical role in diagnostic, pharmaceutical, and research applications. Liquid dispensing systems are essential for accurately handling reagents, buffers, biological samples, and drug formulations in high-throughput environments. Their precision, speed, and compatibility with automated systems make them indispensable in clinical diagnostics (e.g., ELISA, PCR), pharmaceutical R&D, and point-of-care testing workflows. The increasing demand for automated liquid handling, driven by expanding test volumes, biologics manufacturing, and personalized medicine, has significantly boosted adoption. Additionally, advancements in non-contact and tipless dispensing technologies have enabled greater accuracy and minimized contamination, supporting applications that require stringent quality control. As automation, digitalization, and throughput optimization continue to reshape healthcare and laboratory operations, liquid dispensing systems emerge as a prominent technology, providing scalable, efficient, and compliant fluid handling solutions across diverse end users segments. “The Asia Pacific region is expected to register the highest growth rate in the healthcare dispensing systems market during the forecast period.” The global healthcare dispensing systems market is segmented into five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, the Asia Pacific is expected to register the fastest growth in healthcare dispensing systems during the forecast period. This surge is primarily attributed to increased government funding, ongoing expansion in pharmaceutical and diagnostic manufacturing, and the adoption of automation technologies in countries such as China, India, South Korea, and Singapore. Additionally, favorable manufacturing policies, rising foreign direct investment in medtech and biotech sectors, and increased clinical research activity are creating strong demand for high-throughput, automated dispensing solutions. Combined with a focus on improving healthcare accessibility and efficiency, these factors are expected to significantly drive the growth of the healthcare dispensing systems market in Asia Pacific. The breakdown of primary participants is as mentioned below: • By Company Type - Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%) • By Designation - C-level Executives (44%), Director-level (31%), and Others (25%) • By Region - North America (45%), Europe (28%), Asia Pacific (20%), Latin America (4%), Middle East & Africa (3%) Key Players The prominent players in this market are Nordson Corporation (US), DH Life Sciences, LLC (US), ABB (Switzerland), Fisnar (US), PARKER HANNIFIN CORP (US), BioDot (US), Thermo Fisher Scientific Inc. (US), bdtronic (Germany), Agilent Technologies, Inc. (US), Hamilton Company (US), Graco Inc. (US), Imagene Technology Inc (US), Harro Höfliger Verpackungsmaschinen GmbH (Germany), Tecan Trading AG (Switzerland), IVEK Corporation (US), Perkinelmer (US), QIAGEN (Germany), Coperion GmbH (Germany), Ascential Technologies (US), and and LGC Biosearch Technologies (UK). Players adopted organic as well as inorganic growth strategies such as product launches and enhancements, and investments, partnerships, collaborations, joint ventures, funding, acquisition, expansions, agreements, contracts, and alliances to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market. Research Coverage • The report studies the healthcare dispensing systems market based on type, dispensing material, application, end user, and region. • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. • The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total healthcare dispensing systems market. • The report forecasts the revenue of market segments with respect to five major regions. Reasons to Buy the Report The report can help established firms, as well as new entrants/smaller firms, gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below. This report provides insights into the following pointers:  Analysis of key drivers (increasing demand for automation and precision in pharmaceutical and diagnostic workflows, rising adoption of point-of-care and decentralized testing platforms, growing need for high-throughput testing solutions in response to global health challenges, ongoing advancements in liquid handling and non-contact dispensing technologies, expansion of R&D and manufacturing infrastructure by biotech and medtech companies, supportive government initiatives for domestic manufacturing, and the push for digital transformation in clinical laboratories), restraints (high capital investment for advanced dispensing systems, limited adoption in low-resource settings, and technical complexity requiring skilled personnel), opportunities (rising outsourcing of diagnostic manufacturing to contract service providers, increasing investments in personalized medicine and biologics requiring precise micro dispensing, rapid growth in Asia Pacific healthcare infrastructure, demand for integrated cloud-based dispensing systems, and increased use of modular systems in flexible lab automation environments), and challenges (stringent regulatory validation processes, interoperability issues between dispensing systems and lab information systems, supply chain disruptions affecting critical dispensing components, and resistance from traditional labs in adopting automated workflows) influencing the growth of healthcare dispensing systems market).  Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the healthcare dispensing systems market.  Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of healthcare dispensing systems across regions.  Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the healthcare dispensing systems market.  Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the healthcare dispensing systems market.
目錄 Table of Contents
1 INTRODUCTION 34 1.1 STUDY OBJECTIVES 34 1.2 MARKET DEFINITION 34 1.3 STUDY SCOPE 35 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 35 1.3.2 INCLUSIONS & EXCLUSIONS 36 1.3.3 YEARS CONSIDERED 38 1.4 CURRENCY 38 1.5 STAKEHOLDERS 39 2 RESEARCH METHODOLOGY 40 2.1 RESEARCH DATA 40 2.1.1 SECONDARY DATA 41 2.1.1.1 Key data from secondary sources 41 2.1.2 PRIMARY DATA 42 2.1.2.1 Key data from primary sources 43 2.1.2.2 Breakdown of primary sources 45 2.2 MARKET SIZE ESTIMATION 45 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 53 2.4 RESEARCH ASSUMPTIONS 55 2.4.1 MARKET SIZING ASSUMPTIONS 55 2.4.2 OVERALL STUDY ASSUMPTIONS 55 2.5 RISK ASSESSMENT 56 2.6 RESEARCH LIMITATIONS 56 2.6.1 METHODOLOGY-RELATED LIMITATIONS 56 2.6.2 SCOPE-RELATED LIMITATIONS 56 3 EXECUTIVE SUMMARY 57 4 PREMIUM INSIGHTS 61 4.1 HEALTHCARE DISPENSING SYSTEMS MARKET OVERVIEW 61 4.2 HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION 62 4.3 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER & REGION 63 4.4 HEALTHCARE DISPENSING SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 64 4.5 HEALTHCARE DISPENSING SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES 65 5 MARKET OVERVIEW 66 5.1 INTRODUCTION 66 5.1.1 DRIVERS 67 5.1.1.1 Innovation in artificial intelligence and robotic systems 67 5.1.1.2 Biotech and medtech R&D expansion 68 5.1.1.3 Workflow optimization and lab digitization 68 5.1.1.4 Government incentives for advanced manufacturing 69 5.1.2 RESTRAINTS 69 5.1.2.1 High cost of healthcare dispensing systems 69 5.1.2.2 Regulatory and validation burdens 70 5.1.2.3 Limited infrastructure in emerging markets 70 5.1.3 OPPORTUNITIES 70 5.1.3.1 Growing demand from emerging biotech hubs 70 5.1.3.2 Growing partnerships and collaborations 71 5.1.3.3 Increasing healthcare spending across regions 71 5.1.4 CHALLENGES 72 5.1.4.1 System integration challenges with existing laboratory infrastructure 72 5.1.4.2 Shortage of skilled workforce for operating advanced labs 72 5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73 5.3 INDUSTRY TRENDS 74 5.3.1 AUTOMATION AND ROBOTICS ADOPTION 74 5.3.2 AI AND MACHINE LEARNING INTEGRATION 74 5.4 ECOSYSTEM ANALYSIS 74 5.5 VALUE CHAIN ANALYSIS 76 5.6 TECHNOLOGY ANALYSIS 78 5.6.1 KEY TECHNOLOGIES 78 5.6.1.1 Non-contact dispensing technologies 78 5.6.1.2 Pressure-based microfluidic dispensing 78 5.6.1.3 Robotic automation & vision systems 79 5.6.2 COMPLEMENTARY TECHNOLOGIES 79 5.6.2.1 Laboratory information management systems (LIMS) 79 5.6.2.2 Computer-aided design and manufacturing (CAD/CAM) systems 79 5.6.3 ADJACENT TECHNOLOGIES 80 5.6.3.1 Digital twin technology 80 5.6.3.2 3D printing in healthcare dispensing ecosystems 81 5.6.3.3 AI-driven predictive maintenance for dispensing systems 81 5.7 REGULATORY ANALYSIS 81 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 5.7.2 REGULATORY ANALYSIS 85 5.7.2.1 North America 85 5.7.2.2 Europe 86 5.7.2.3 Asia Pacific 87 5.7.2.4 Middle East & Africa 88 5.7.2.5 Latin America 89 5.8 PRICING ANALYSIS 90 5.8.1 INDICATIVE PRICING FOR HEALTHCARE DISPENSING SYSTEMS, BY PRODUCT (2024) 90 5.8.2 INDICATIVE PRICING FOR HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION, 2024 91 5.9 PORTER’S FIVE FORCES ANALYSIS 92 5.9.1 INTENSITY OF COMPETITIVE RIVALRY 94 5.9.2 BARGAINING POWER OF BUYERS 94 5.9.3 THREAT OF SUBSTITUTES 94 5.9.4 THREAT OF NEW ENTRANTS 94 5.9.5 BARGAINING POWER OF SUPPLIERS 95 5.10 PATENT ANALYSIS 95 5.10.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE DISPENSING SYSTEMS MARKET 95 5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR HEALTHCARE DISPENSING SYSTEMS MARKET 96 5.10.3 MAJOR PATENTS IN HEALTHCARE DISPENSING SYSTEMS MARKET 97 5.11 KEY STAKEHOLDERS & BUYING CRITERIA 97 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 97 5.11.2 KEY BUYING CRITERIA 98 5.12 END-USER ANALYSIS 99 5.12.1 UNMET NEEDS 99 5.12.2 END-USER EXPECTATIONS 100 5.13 KEY CONFERENCES & EVENTS, 2025–2026 101 5.14 CASE STUDY ANALYSIS 102 5.15 TRADE ANALYSIS 104 5.15.1 IMPORT SCENARIO (HS CODE 8413) 104 5.15.2 EXPORT SCENARIO (HS CODE 8413) 105 5.16 INVESTMENT & FUNDING SCENARIO 106 5.17 IMPACT OF 2025 US TARIFFS ON HEALTHCARE DISPENSING SYSTEMS MARKET 109 5.17.1 KEY TARIFF RATES 109 5.17.2 PRICE IMPACT ANALYSIS 110 5.17.3 IMPACT ON COUNTRY/REGION 110 5.17.3.1 US 110 5.17.3.2 Europe 112 5.17.3.3 APAC 113 5.17.4 IMPACT ON END-USE INDUSTRIES 113 6 HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE 115 6.1 INTRODUCTION 116 6.2 AUTOMATIC DISPENSING SYSTEMS 117 6.2.1 GROWING DEMAND FOR PRECISION, STERILITY, AND LAB AUTOMATION TO BOOST ADOPTION OF AUTOMATIC DISPENSING SYSTEMS 117 6.3 SEMI-AUTOMATIC DISPENSING SYSTEMS 118 6.3.1 RISING R&D AND MID-VOLUME LAB DEMAND TO DRIVE DEMAND FOR COST-EFFECTIVE SEMI-AUTOMATED DISPENSING SYSTEMS 118 6.4 STANDALONE/MANUAL DISPENSING SYSTEMS 119 6.4.1 VITAL ROLE OF MANUAL DISPENSING TOOLS IN LOW-RESOURCE, HIGH-CUSTOMIZATION LAB SETTINGS TO SUPPORT MARKET GROWTH 119 6.5 OEM/DISPENSING COMPONENTS 120 6.5.1 PUMPS 121 6.5.1.1 Ability of precision pumps to power sterile, compliant fluid handling across healthcare workflows to drive growth 121 6.5.2 VALVES & NOZZLES 122 6.5.2.1 Ability of valves & nozzles to enable precision, contamination-free fluid control in automated dispensing to boost market 122 6.5.3 CONTROL SYSTEMS 123 6.5.3.1 Ability of control systems to drive intelligent, compliant automation in healthcare dispensing to contribute to growth 123 6.5.4 OTHER OEM COMPONENTS 124 7 HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL 125 7.1 INTRODUCTION 126 7.2 LIQUIDS 126 7.2.1 REAGENTS 127 7.2.1.1 Growing automation needs in diagnostics, genomics, and biomanufacturing to boost demand for reagent dispensing systems 127 7.2.2 BUFFERS 128 7.2.2.1 High demand for scalable, validated workflows in biologics and diagnostics to boost market for buffer dispensing systems 128 7.2.3 ANTIBODIES 129 7.2.3.1 Rising demand for ultra-precise diagnostic and therapeutic applications to boost demand for antibody dispensing systems 129 7.2.4 OTHER LIQUIDS 130 7.3 POWDERS, GRANULES, AND LYOPHILIZED MATERIALS 131 7.3.1 CAKES 132 7.3.1.1 Growing demand for high-precision injectable and diagnostic products to boost market for lyophilized cake dispensing 132 7.3.2 LYOBEADS 133 7.3.2.1 Ability of lyobeads to power cold chain-free diagnostics and therapeutics to drive growth 133 7.3.3 OTHER POWDERS, GRANULES, AND LYOPHILIZED MATERIALS 134 7.4 OTHER MATERIALS 135 8 HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION 137 8.1 INTRODUCTION 138 8.2 PHARMACEUTICAL & BIOTECHNOLOGY 138 8.2.1 R&D 139 8.2.1.1 Pivotal role of R&D in precise dispensing systems to support growth 139 8.2.2 MANUFACTURING & QA/QC 140 8.2.2.1 Advancing quality control with intelligent dispensing in pharma & biotech manufacturing to fuel growth 140 8.3 DIAGNOSTICS & POC TESTING 141 8.3.1 LATERAL FLOW ASSAYS & RAPID TESTS 143 8.3.1.1 Ability of these tests to enable scalable production with precision dispensing systems to boost market 143 8.3.2 PCR & NUCLEIC ACID TESTS 143 8.3.2.1 Ability of dispensing systems to advance PCR & NAAT efficiency to fuel growth 143 8.3.3 IMMUNOASSAYS & ELISA TESTS 144 8.3.3.1 Ability of automated dispensing systems to power high-throughput immunoassays to propel growth 144 8.3.4 MICROARRAYS 145 8.3.4.1 High-density assay precision with advanced dispensing systems to drive demand 145 8.3.5 IMMUNOBLOTS 146 8.3.5.1 Growing need to automate immunoblot workflows to drive market 146 8.3.6 MICROFLUIDICS & LAB-ON-A-CHIP TESTS 147 8.3.6.1 Advantages of dispensing systems in microfluidic and lab-on-a-chip technologies to support market 147 8.3.7 OTHER DIAGNOSTICS & POC TESTING APPLICATIONS 147 8.4 MEDICAL DEVICE MANUFACTURING 148 8.4.1 DRUG DELIVERY DEVICES 150 8.4.1.1 Advantages such as precision filling and coating with advanced dispensing systems to boost market 150 8.4.2 IMPLANTABLE MEDICAL DEVICES 150 8.4.2.1 Growing need for dispensing of coatings, drug layers, and biocompatible materials to support market 150 8.4.3 SURGICAL INSTRUMENTS & WOUND CARE DEVICES 151 8.4.3.1 Ability of dispensing systems to drive quality and sterility in surgical and wound care devices to fuel growth 151 8.4.4 DIAGNOSTIC TEST KIT MANUFACTURING 152 8.4.4.1 Vital role of dispensing technologies in supporting medical-grade devices to drive growth 152 8.4.5 OTHER MEDICAL DEVICE MANUFACTURING APPLICATIONS 153 8.5 PHARMACY MANAGEMENT 154 8.5.1 INCREASING INTEGRATION OF DISPENSING SYSTEMS IN PHARMACY MANAGEMENT TO DRIVE GROWTH 154 8.6 OTHER APPLICATIONS 155 9 HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER 157 9.1 INTRODUCTION 158 9.2 HEALTHCARE PROVIDERS 158 9.2.1 HOSPITALS 160 9.2.1.1 High test volumes and strong push for automation to boost market growth 160 9.2.2 DIAGNOSTIC LABS 161 9.2.2.1 Need for precise, high-throughput dispensing in clinical testing to drive demand in diagnostic labs 161 9.2.3 OUTPATIENT SETTINGS 162 9.2.3.1 Need for patient safety in outpatient settings to boost segmental growth 162 9.2.4 HOME HEALTHCARE, LONG-TERM CARE, AND ASSISTED LIVING FACILITIES 163 9.2.4.1 Need to support decentralized, high-throughput care and ensure regulatory compliance to boost adoption 163 9.2.5 PHARMACIES 164 9.2.5.1 Growing need for technology to assist with faster prescription filling and medication dispensing to drive market growth 164 9.2.6 OTHER HEALTHCARE PROVIDERS 165 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 166 9.3.1 GROWING IMPORTANCE OF AUTOMATION TO ENHANCE DRUG DEVELOPMENT SPEED AND ACCURACY TO BOOST DEMAND 166 9.4 MEDTECH COMPANIES 167 9.4.1 GROWING ADOPTION OF PRECISION DISPENSING SYSTEMS TO SUPPORT DEVICE MINIATURIZATION 167 9.5 OTHER END USERS 168 10 HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION 170 10.1 INTRODUCTION 171 10.2 NORTH AMERICA 171 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 172 10.2.2 US 179 10.2.2.1 US to dominate North American healthcare dispensing systems market 179 10.2.3 CANADA 185 10.2.3.1 Strong demand for pharmacy automation to propel market 185 10.3 EUROPE 190 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 191 10.3.2 GERMANY 198 10.3.2.1 Germany to dominate European healthcare dispensing systems market during forecast period 198 10.3.3 UK 204 10.3.3.1 Strong support for life science R&D and well-developed infrastructure to aid market 204 10.3.4 FRANCE 210 10.3.4.1 Increasing investment in R&D and funding for life sciences to drive growth 210 10.3.5 ITALY 216 10.3.5.1 Advancements in laboratory systems to drive growth 216 10.3.6 SPAIN 222 10.3.6.1 Expanding medical diagnostics research to propel market growth 222 10.3.7 REST OF EUROPE 228 10.4 ASIA PACIFIC 234 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 236 10.4.2 CHINA 242 10.4.2.1 China to grow at highest growth rate during forecast period 242 10.4.3 JAPAN 248 10.4.3.1 Japan to dominate Asia Pacific healthcare dispensing systems market 248 10.4.4 INDIA 254 10.4.4.1 Expansion of biotech sector, coupled with supportive government policies, to fuel market growth 254 10.4.5 REST OF ASIA 260 10.5 LATIN AMERICA 266 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 266 10.5.2 BRAZIL 273 10.5.2.1 Growing public and private initiatives supporting scientific research to drive growth 273 10.5.3 MEXICO 278 10.5.3.1 Thriving pharmaceutical industry to drive market 278 10.5.4 REST OF LATIN AMERICA 284 10.6 MIDDLE EAST & AFRICA 290 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 290 10.6.2 GCC COUNTRIES 297 10.6.2.1 Improvements in healthcare infrastructure to support market growth 297 10.6.3 REST OF MIDDLE EAST & AFRICA 302 11 COMPETITIVE LANDSCAPE 309 11.1 OVERVIEW 309 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 309 11.3 REVENUE ANALYSIS, 2020–2024 313 11.4 MARKET SHARE ANALYSIS, 2024 314 11.5 RANKING OF KEY MARKET PLAYERS 318 11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 318 11.6.1 STARS 319 11.6.2 EMERGING LEADERS 319 11.6.3 PERVASIVE PLAYERS 319 11.6.4 PARTICIPANTS 319 11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 321 11.6.5.1 Company footprint 321 11.6.5.2 Region footprint 322 11.6.5.3 Type footprint 323 11.6.5.4 Material footprint 324 11.6.5.5 Application footprint 325 11.6.5.6 End-user footprint 326 11.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 327 11.7.1 PROGRESSIVE COMPANIES 327 11.7.2 RESPONSIVE COMPANIES 327 11.7.3 DYNAMIC COMPANIES 327 11.7.4 STARTING BLOCKS 327 11.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 328 11.7.5.1 Detailed list of key startups/SMEs 328 11.7.5.2 Competitive benchmarking of startups/SMEs 329 11.8 COMPANY VALUATION & FINANCIAL METRICS 330 11.9 BRAND/PRODUCT COMPARISON 331 11.10 COMPETITIVE SCENARIO 332 11.10.1 PRODUCT LAUNCHES 332 11.10.2 DEALS 334 11.10.3 EXPANSIONS 336 12 COMPANY PROFILES 337 12.1 KEY PLAYERS 337 12.1.1 NORDSON CORPORATION 337 12.1.1.1 Business overview 337 12.1.1.2 Products offered 339 12.1.1.3 Recent developments 342 12.1.1.3.1 Product launches 342 12.1.1.3.2 Deals 342 12.1.1.3.3 Expansions 343 12.1.1.4 MnM view 343 12.1.1.4.1 Right to win 343 12.1.1.4.2 Strategic choices 343 12.1.1.4.3 Weaknesses & competitive threats 343 12.1.2 AGILENT TECHNOLOGIES, INC. 344 12.1.2.1 Business overview 344 12.1.2.2 Products offered 346 12.1.2.3 Recent developments 346 12.1.2.3.1 Product launches 346 12.1.2.3.2 Deals 347 12.1.2.4 MnM view 347 12.1.2.4.1 Right to win 347 12.1.2.4.2 Strategic choices 347 12.1.2.4.3 Weaknesses & competitive threats 347 12.1.3 DANAHER CORPORATION 348 12.1.3.1 Business overview 348 12.1.3.2 Products offered 350 12.1.3.3 Recent developments 350 12.1.3.3.1 Deals 350 12.1.3.4 MnM view 351 12.1.3.4.1 Right to win 351 12.1.3.4.2 Strategic choices 351 12.1.3.4.3 Weaknesses & competitive threats 351 12.1.4 THERMO FISHER SCIENTIFIC INC. 352 12.1.4.1 Business overview 352 12.1.4.2 Products offered 354 12.1.4.3 Recent developments 355 12.1.4.3.1 Expansions 355 12.1.4.4 MnM view 355 12.1.4.4.1 Right to win 355 12.1.4.4.2 Strategic choices 355 12.1.4.4.3 Weaknesses & competitive threats 356 12.1.5 BIODOT 357 12.1.5.1 Business overview 357 12.1.5.2 Products offered 357 12.1.5.3 Recent developments 358 12.1.5.3.1 Product launches 358 12.1.5.3.2 Deals 359 12.1.5.4 MnM view 359 12.1.5.4.1 Right to win 359 12.1.5.4.2 Strategic choices 359 12.1.5.4.3 Weaknesses & competitive threats 359 12.1.6 FISNAR 360 12.1.6.1 Business overview 360 12.1.6.2 Products offered 360 12.1.7 PARKER-HANNIFIN CORPORATION 363 12.1.7.1 Business overview 363 12.1.7.2 Products offered 364 12.1.8 BDTRONIC 365 12.1.8.1 Business overview 365 12.1.8.2 Products offered 365 12.1.9 HAMILTON COMPANY 367 12.1.9.1 Business overview 367 12.1.9.2 Products offered 367 12.1.9.3 Recent developments 368 12.1.9.3.1 Product launches 368 12.1.9.3.2 Deals 369 12.1.10 GRACO INC. 370 12.1.10.1 Business overview 370 12.1.10.2 Products offered 372 12.1.10.3 Recent developments 372 12.1.10.3.1 Product launches 372 12.1.11 REVVITY, INC. 373 12.1.11.1 Business overview 373 12.1.11.2 Products offered 375 12.1.12 HARRO HÖFLIGER VERPACKUNGSMASCHINEN GMBH 377 12.1.12.1 Business overview 377 12.1.12.2 Products offered 377 12.1.12.3 Recent developments 378 12.1.12.3.1 Deals 378 12.1.13 TECAN TRADING AG 379 12.1.13.1 Business overview 379 12.1.13.2 Products offered 380 12.1.14 IVEK CORPORATION 382 12.1.14.1 Business overview 382 12.1.14.2 Products offered 382 12.1.15 IMAGENE TECHNOLOGY INC. 384 12.1.15.1 Business overview 384 12.1.15.2 Products offered 384 12.1.16 QIAGEN 385 12.1.16.1 Business overview 385 12.1.16.2 Products offered 387 12.1.17 BRAND GMBH + CO KG 388 12.1.17.1 Business overview 388 12.1.17.2 Products offered 388 12.1.18 ASCENTIAL TECHNOLOGIES 389 12.1.18.1 Business overview 389 12.1.18.2 Products offered 389 12.1.18.3 Recent developments 390 12.1.18.3.1 Expansions 390 12.1.18.3.2 Other developments 390 12.1.19 LGC BIOSEARCH TECHNOLOGIES 391 12.1.19.1 Business overview 391 12.1.19.2 Products offered 391 12.1.19.3 Recent developments 392 12.1.19.3.1 Deals 392 12.1.20 GILSON INCORPORATED 393 12.1.20.1 Business overview 393 12.1.20.2 Products offered 393 12.2 OTHER PLAYERS 394 12.2.1 CLAREMONT BIOSOLUTIONS, LLC 394 12.2.2 GUANGZHOU ASCEND PRECISION MACHINERY CO., LTD. 395 12.2.3 RADETEC PTY LTD. 396 12.2.4 BAODING CHUANGRUI PRECISION PUMP CO., LTD. 397 12.2.5 ELVEFLOW 398 13 APPENDIX 399 13.1 DISCUSSION GUIDE 399 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 404 13.3 CUSTOMIZATION OPTIONS 406 13.4 RELATED REPORTS 407 13.5 AUTHOR DETAILS 408
圖表清單 List of Tables & Figures
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 38 TABLE 2 HEALTHCARE DISPENSING SYSTEMS MARKET: FACTOR ANALYSIS 51 TABLE 3 HEALTHCARE DISPENSING SYSTEMS MARKET: RISK ASSESSMENT 56 TABLE 4 HEALTHCARE DISPENSING SYSTEMS MARKET: MARKET DYNAMICS 67 TABLE 5 HEALTHCARE DISPENSING SYSTEMS MARKET: ROLE IN ECOSYSTEM 76 TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 11 REGULATORY SCENARIO OF NORTH AMERICA 85 TABLE 12 REGULATORY SCENARIO OF EUROPE 86 TABLE 13 REGULATORY SCENARIO OF ASIA PACIFIC 87 TABLE 14 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 88 TABLE 15 REGULATORY SCENARIO OF LATIN AMERICA 89 TABLE 16 INDICATIVE PRICING FOR HEALTHCARE DISPENSING SYSTEMS MARKET, BY PRODUCT (2024) 91 TABLE 17 INDICATIVE PRICING OF HEALTHCARE DISPENSING SYSTEMS, BY REGION, 2024 92 TABLE 18 HEALTHCARE DISPENSING SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS 93 TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRODUCTS, BY END USER (%) 98 TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEALTHCARE DISPENSING SYSTEMS FOR KEY END USERS 99 TABLE 21 UNMET NEEDS IN HEALTHCARE DISPENSING SYSTEMS MARKET 99 TABLE 22 END-USER EXPECTATIONS IN HEALTHCARE DISPENSING SYSTEMS MARKET 100 TABLE 23 LIST OF KEY CONFERENCES & EVENTS IN HEALTHCARE DISPENSING SYSTEMS MARKET, JANUARY 2025–DECEMBER 2026 101 TABLE 24 CASE STUDY 1: AUTOMATING BIOREACTOR WORKFLOWS WITH CELLEXUS & WATSON-MARLOW PUMPS 102 TABLE 25 CASE STUDY 2: REDUCING MEDICATION RE-DISPENSES THROUGH BARCODE-ENABLED DISPENSING SYSTEM INTEGRATION AT A U.S. HEALTH SYSTEM 103 TABLE 26 CASE STUDY 3: SCALING PRESCRIPTION FULFILLMENT WITH AN AUTOMATED DISPENSING SYSTEM FOR HIGH-VOLUME PHARMACY OPERATIONS 103 TABLE 27 IMPORT SCENARIO FOR PUMPS FOR LIQUIDS, WHETHER OR NOT FITTED WITH A MEASURING DEVICE [EXCL. (HS CODE 8413)], BY COUNTRY, 2020–2024 (USD THOUSAND) 104 TABLE 28 EXPORT SCENARIO FOR PUMPS FOR LIQUIDS, WHETHER OR NOT FITTED WITH A MEASURING DEVICE [EXCL. (HS CODE 8413)], BY COUNTRY, 2020–2024 (USD THOUSAND) 105 TABLE 29 US-ADJUSTED RECIPROCAL TARIFF RATES 109 TABLE 30 HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 116 TABLE 31 HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS) 116 TABLE 32 AUTOMATIC DISPENSING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 33 SEMI-AUTOMATIC DISPENSING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 34 STANDALONE/MANUAL DISPENSING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 35 OEM/DISPENSING COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 36 OEM/DISPENSING COMPONENTS MARKET FOR PUMPS, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 37 OEM/DISPENSING COMPONENTS MARKET FOR VALVES & NOZZLES, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 38 OEM/DISPENSING COMPONENTS MARKET FOR CONTROL SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 39 OTHER OEM/DISPENSING COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 40 HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 126 TABLE 41 HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 42 HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 127 TABLE 43 HEALTHCARE DISPENSING SYSTEMS MARKET FOR REAGENTS, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 44 HEALTHCARE DISPENSING SYSTEMS MARKET FOR BUFFERS, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 45 HEALTHCARE DISPENSING SYSTEMS MARKET FOR ANTIBODIES, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 46 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER LIQUIDS, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 47 HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 48 HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 132 TABLE 49 HEALTHCARE DISPENSING SYSTEMS MARKET FOR CAKES, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 50 HEALTHCARE DISPENSING SYSTEMS MARKET FOR LYOBEADS, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 51 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 52 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER MATERIALS, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 53 HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 138 TABLE 54 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 55 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 139 TABLE 56 HEALTHCARE DISPENSING SYSTEMS MARKET FOR R&D APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 57 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MANUFACTURING & QA/QC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 58 HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 142 TABLE 59 HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 142 TABLE 60 HEALTHCARE DISPENSING SYSTEMS MARKET FOR LATERAL FLOW ASSAYS & RAPID TESTS, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 61 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PCR & NUCLEIC ACID TESTS, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 62 HEALTHCARE DISPENSING SYSTEMS MARKET FOR IMMUNOASSAYS & ELISA TESTS, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 63 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MICROARRAYS, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 64 HEALTHCARE DISPENSING SYSTEMS MARKET FOR IMMUNOBLOTS, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 65 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MICROFLUIDICS & LAB-ON-A-CHIP TESTS, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 66 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER DIAGNOSTICS & POC TESTING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 67 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 68 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 69 HEALTHCARE DISPENSING SYSTEMS MARKET FOR DRUG DELIVERY DEVICES, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 70 HEALTHCARE DISPENSING SYSTEMS MARKET FOR IMPLANTABLE MEDICAL DEVICES, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 71 HEALTHCARE DISPENSING SYSTEMS MARKET FOR SURGICAL INSTRUMENTS & WOUND CARE DEVICES, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 72 HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTIC TEST KIT MANUFACTURING, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 73 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 74 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACY MANAGEMENT APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 75 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 76 HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 158 TABLE 77 HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 159 TABLE 78 HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 79 HEALTHCARE DISPENSING SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 80 HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTIC LABS, BY REGION, 2023–2030 (USD MILLION) 162 TABLE 81 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OUTPATIENT SETTINGS, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 82 HEALTHCARE DISPENSING SYSTEMS MARKET FOR HOME HEALTHCARE, LONG-TERM CARE, AND ASSISTED LIVING FACILITIES, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 83 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACIES, BY REGION, 2023–2030 (USD MILLION) 165 TABLE 84 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 85 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 167 TABLE 86 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION) 168 TABLE 87 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 169 TABLE 88 HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 171 TABLE 89 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 90 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 91 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 92 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 174 TABLE 93 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 94 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 95 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 176 TABLE 96 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 97 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 98 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 99 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 178 TABLE 100 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 101 US: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 102 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 103 US: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 180 TABLE 104 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 105 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 106 US: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 182 TABLE 107 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 108 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 109 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 110 US: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 184 TABLE 111 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 112 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 113 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 114 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 186 TABLE 115 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 116 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 117 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 188 TABLE 118 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 119 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 120 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 121 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 190 TABLE 122 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 123 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 124 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 125 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 126 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 193 TABLE 127 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 128 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 129 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 195 TABLE 130 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 131 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 132 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 133 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 197 TABLE 134 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 135 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 136 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 137 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 199 TABLE 138 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 139 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 140 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 201 TABLE 141 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 142 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 143 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 144 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 203 TABLE 145 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 146 UK: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 147 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 148 UK: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 205 TABLE 149 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 150 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 151 UK: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 207 TABLE 152 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 153 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 154 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 155 UK: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 209 TABLE 156 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 157 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 158 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 159 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 211 TABLE 160 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 161 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 162 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 213 TABLE 163 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 164 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 165 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 166 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 215 TABLE 167 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 168 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 169 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 170 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 217 TABLE 171 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 172 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 173 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 219 TABLE 174 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 175 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 176 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 177 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 221 TABLE 178 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 179 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 180 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 181 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 223 TABLE 182 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 183 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 184 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 225 TABLE 185 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 186 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 187 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 188 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 227 TABLE 189 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 190 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 191 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 192 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 229 TABLE 193 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 194 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 195 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 231 TABLE 196 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 197 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 198 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 199 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 233 TABLE 200 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 201 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 236 TABLE 202 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 203 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 204 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 238 TABLE 205 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 206 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 207 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 239 TABLE 208 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 209 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 210 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 211 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 241 TABLE 212 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 213 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 214 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 215 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 244 TABLE 216 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 217 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 218 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 245 TABLE 219 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 220 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 221 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 222 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 247 TABLE 223 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 224 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 225 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 226 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 250 TABLE 227 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 228 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 229 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 251 TABLE 230 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 231 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 232 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 233 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 253 TABLE 234 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 235 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 236 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 237 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 256 TABLE 238 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 239 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 240 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 257 TABLE 241 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 242 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 243 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 244 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 259 TABLE 245 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 246 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 247 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 248 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 262 TABLE 249 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 250 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 251 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 263 TABLE 252 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 253 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 254 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 255 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 265 TABLE 256 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 257 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 267 TABLE 258 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 259 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 260 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 268 TABLE 261 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 262 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 263 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 270 TABLE 264 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 265 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 266 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 267 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 272 TABLE 268 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 269 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 270 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 271 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 274 TABLE 272 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 273 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 274 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 276 TABLE 275 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 276 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 277 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 278 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 278 TABLE 279 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 280 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 281 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 282 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 280 TABLE 283 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 284 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 285 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 281 TABLE 286 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 287 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 288 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 289 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 283 TABLE 290 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 291 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 292 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 293 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 286 TABLE 294 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 295 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 296 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 287 TABLE 297 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 298 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 299 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 300 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 289 TABLE 301 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 302 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 291 TABLE 303 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 304 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 305 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 292 TABLE 306 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 307 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 308 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 294 TABLE 309 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 310 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 311 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 312 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 296 TABLE 313 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 314 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 315 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 316 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 298 TABLE 317 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 318 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 319 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 300 TABLE 320 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 321 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 322 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 323 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 302 TABLE 324 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 325 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 326 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 327 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 304 TABLE 328 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 329 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 330 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 305 TABLE 331 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 332 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 333 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 334 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 307 TABLE 335 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 336 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE DISPENSING SYSTEMS MARKET, JANUARY 2022–JUNE 2025 310 TABLE 337 HEALTHCARE DISPENSING SYSTEMS MARKET: DEGREE OF COMPETITION 315 TABLE 338 HEALTHCARE DISPENSING SYSTEMS MARKET: REGION FOOTPRINT 322 TABLE 339 HEALTHCARE DISPENSING SYSTEMS MARKET: TYPE FOOTPRINT 323 TABLE 340 HEALTHCARE DISPENSING SYSTEMS MARKET: MATERIAL FOOTPRINT 324 TABLE 341 HEALTHCARE DISPENSING SYSTEMS MARKET: APPLICATION FOOTPRINT 325 TABLE 342 HEALTHCARE DISPENSING SYSTEMS MARKET: END-USER FOOTPRINT 326 TABLE 343 HEALTHCARE DISPENSING SYSTEMS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 328 TABLE 344 HEALTHCARE DISPENSING SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 329 TABLE 345 HEALTHCARE DISPENSING SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY TYPE 329 TABLE 346 HEALTHCARE DISPENSING SYSTEMS MARKET: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 333 TABLE 347 HEALTHCARE DISPENSING SYSTEMS MARKET: DEALS, JANUARY 2022–JULY 2025 334 TABLE 348 HEALTHCARE DISPENSING SYSTEMS MARKET: EXPANSIONS, JANUARY 2022–MAY 2025 336 TABLE 349 NORDSON CORPORATION: COMPANY OVERVIEW 337 TABLE 350 NORDSON CORPORATION: PRODUCTS OFFERED 339 TABLE 351 NORDSON CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 342 TABLE 352 NORDSON CORPORATION: DEALS, JANUARY 2022–MAY 2025 342 TABLE 353 NORDSON CORPORATION: EXPANSIONS, JANUARY 2022–MAY 2025 343 TABLE 354 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 344 TABLE 355 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 346 TABLE 356 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 346 TABLE 357 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022–MAY 2025 347 TABLE 358 DANAHER CORPORATION: COMPANY OVERVIEW 348 TABLE 359 DANAHER CORPORATION: PRODUCTS OFFERED 350 TABLE 360 DANAHER CORPORATION: DEALS, JANUARY 2022–MAY 2025 350 TABLE 361 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 352 TABLE 362 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 354 TABLE 363 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022–MAY 2025 355 TABLE 364 BIODOT: COMPANY OVERVIEW 357 TABLE 365 BIODOT: PRODUCTS OFFERED 357 TABLE 366 BIODOT: PRODUCT LAUNCHES, JANUARY 2022– MAY 2025 358 TABLE 367 BIODOT: DEALS, JANUARY 2022– MAY 2025 359 TABLE 368 FISNAR: COMPANY OVERVIEW 360 TABLE 369 FISNAR: PRODUCTS OFFERED 360 TABLE 370 PARKER-HANNIFIN CORPORATION: COMPANY OVERVIEW 363 TABLE 371 PARKER-HANNIFIN CORPORATION: PRODUCTS OFFERED 364 TABLE 372 BDTRONIC: COMPANY OVERVIEW 365 TABLE 373 BDTRONIC: PRODUCTS OFFERED 365 TABLE 374 HAMILTON COMPANY: COMPANY OVERVIEW 367 TABLE 375 HAMILTON COMPANY: PRODUCTS OFFERED 367 TABLE 376 HAMILTON COMPANY: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 368 TABLE 377 HAMILTON COMPANY: DEALS, JANUARY 2022–MAY 2025 369 TABLE 378 GRACO INC.: COMPANY OVERVIEW 370 TABLE 379 GRACO INC.: PRODUCTS OFFERED 372 TABLE 380 GRACO INC.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 372 TABLE 381 REVVITY, INC.: COMPANY OVERVIEW 373 TABLE 382 REVVITY, INC.: PRODUCTS OFFERED 375 TABLE 383 HARRO HÖFLIGER VERPACKUNGSMASCHINEN GMBH: COMPANY OVERVIEW 377 TABLE 384 HARRO HÖFLIGER VERPACKUNGSMASCHINEN GMBH: PRODUCTS OFFERED 377 TABLE 385 HARRO HÖFLIGER VERPACKUNGSMASCHINEN GMBH: DEALS, JANUARY 2022–MAY 2025 378 TABLE 386 TECAN TRADING AG: COMPANY OVERVIEW 379 TABLE 387 TECAN TRADING AG: PRODUCTS OFFERED 380 TABLE 388 IVEK CORPORATION: COMPANY OVERVIEW 382 TABLE 389 IVEK CORPORATION: PRODUCTS OFFERED 382 TABLE 390 IMAGENE TECHNOLOGY INC.: COMPANY OVERVIEW 384 TABLE 391 IMAGENE TECHNOLOGY INC.: PRODUCTS OFFERED 384 TABLE 392 QIAGEN: COMPANY OVERVIEW 385 TABLE 393 QIAGEN: PRODUCTS OFFERED 387 TABLE 394 BRAND GMBH + CO KG: COMPANY OVERVIEW 388 TABLE 395 BRAND GMBH + CO KG: PRODUCTS OFFERED 388 TABLE 396 ASCENTIAL TECHNOLOGIES: COMPANY OVERVIEW 389 TABLE 397 ASCENTIAL TECHNOLOGIES: PRODUCTS OFFERED 389 TABLE 398 ASCENTIAL TECHNOLOGIES: EXPANSIONS, JANUARY 2022–MAY 2025 390 TABLE 399 ASCENTIAL TECHNOLOGIES: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 390 TABLE 400 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW 391 TABLE 401 LGC BIOSEARCH TECHNOLOGIES: PRODUCTS OFFERED 391 TABLE 402 LGC BIOSEARCH TECHNOLOGIES: DEALS, JANUARY 2022–MAY 2025 392 TABLE 403 GILSON INCORPORATED: COMPANY OVERVIEW 393 TABLE 404 GILSON INCORPORATED: PRODUCTS OFFERED 393 TABLE 405 CLAREMONT BIOSOLUTIONS, LLC: COMPANY OVERVIEW 394 TABLE 406 GUANGZHOU ASCEND PRECISION MACHINERY CO., LTD.: COMPANY OVERVIEW 395 TABLE 407 RADETEC PTY LTD.: COMPANY OVERVIEW 396 TABLE 408 BAODING CHUANGRUI PRECISION PUMP CO., LTD.: COMPANY OVERVIEW 397 TABLE 409 ELVEFLOW: COMPANY OVERVIEW 398 FIGURE 1 HEALTHCARE DISPENSING SYSTEMS MARKET SEGMENTATION & REGIONAL SCOPE 35 FIGURE 2 RESEARCH DESIGN 40 FIGURE 3 PRIMARY SOURCES 42 FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS 44 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45 FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 46 FIGURE 7 HEALTHCARE DISPENSING SYSTEMS MARKET: SUPPLY-SIDE MARKET ESTIMATION 47 FIGURE 8 HEALTHCARE DISPENSING SYSTEMS MARKET: REVENUE ESTIMATION APPROACH 48 FIGURE 9 BOTTOM-UP APPROACH: END-USER SPENDING ON HEALTHCARE DISPENSING SYSTEMS 49 FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 52 FIGURE 11 HEALTHCARE DISPENSING SYSTEMS MARKET: CAGR PROJECTIONS 52 FIGURE 12 TOP-DOWN APPROACH 53 FIGURE 13 DATA TRIANGULATION METHODOLOGY 54 FIGURE 14 HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 57 FIGURE 15 HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2025 VS. 2030 (USD MILLION) 58 FIGURE 16 HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 58 FIGURE 17 HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 59 FIGURE 18 HEALTHCARE DISPENSING SYSTEMS MARKET: GEOGRAPHICAL SNAPSHOT 60 FIGURE 19 GROWING FOCUS ON AUTOMATION DISPENSING AND FAVORABLE GOVERNMENT SUPPORT AND FUNDING TO DRIVE MARKET 61 FIGURE 20 NORTH AMERICA TO DOMINATE HEALTHCARE DISPENSING SYSTEMS MARKET DURING FORECAST PERIOD 62 FIGURE 21 PHARMACEUTICAL COMPANIES IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 63 FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 64 FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 65 FIGURE 24 HEALTHCARE DISPENSING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66 FIGURE 25 HEALTHCARE DISPENSING SYSTEMS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73 FIGURE 26 HEALTHCARE DISPENSING SYSTEMS MARKET: ECOSYSTEM ANALYSIS 75 FIGURE 27 HEALTHCARE DISPENSING SYSTEMS MARKET: VALUE CHAIN ANALYSIS 77 FIGURE 28 HEALTHCARE DISPENSING SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS 93 FIGURE 29 GLOBAL PATENTS GRANTED IN HEALTHCARE DISPENSING SYSTEMS MARKET, 2015–2024 96 FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR “REAGENT DISPENSING SYSTEMS” PATENTS (JANUARY 2015–JUNE 2025) 96 FIGURE 31 MAJOR PATENTS IN HEALTHCARE DISPENSING SYSTEMS MARKET (JANUARY 2015–JUNE 2025) 97 FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 98 FIGURE 33 KEY BUYING CRITERIA FOR TOP END USERS 99 FIGURE 34 HEALTHCARE DISPENSING SYSTEMS MARKET: IMPORT SCENARIO FOR HS CODE 8413, 2020–2024 104 FIGURE 35 HEALTHCARE DISPENSING SYSTEMS MARKET: EXPORT SCENARIO FOR HS CODE 8413, 2020–2024 105 FIGURE 39 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET SNAPSHOT 172 FIGURE 40 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET SNAPSHOT 235 FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE DISPENSING SYSTEMS MARKET, 2020–2024 (USD MILLION) 314 FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEALTHCARE DISPENSING SYSTEMS MARKET (2024) 315 FIGURE 43 RANKING OF KEY PLAYERS IN HEALTHCARE DISPENSING SYSTEMS MARKET, 2024 318 FIGURE 44 HEALTHCARE DISPENSING SYSTEMS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 320 FIGURE 45 HEALTHCARE DISPENSING SYSTEMS MARKET: COMPANY FOOTPRINT 321 FIGURE 46 HEALTHCARE DISPENSING SYSTEMS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 328 FIGURE 47 EV/EBITDA OF KEY VENDORS, 2024 330 FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF HEALTHCARE DISPENSING SYSTEM VENDORS, 2024 330 FIGURE 49 HEALTHCARE DISPENSING SYSTEMS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 331 FIGURE 50 NORDSON CORPORATION: COMPANY SNAPSHOT (2024) 338 FIGURE 51 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 345 FIGURE 52 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 349 FIGURE 53 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 353 FIGURE 54 PARKER-HANNIFIN CORPORATION: COMPANY SNAPSHOT (2024) 364 FIGURE 55 GRACO INC.: COMPANY SNAPSHOT (2024) 371 FIGURE 56 REVVITY, INC.: COMPANY SNAPSHOT (2024) 374 FIGURE 57 TECAN TRADING AG: COMPANY SNAPSHOT (2024) 380 FIGURE 58 QIAGEN: COMPANY SNAPSHOT (2024) 386

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們